Determination of cyclosporine levels in central venous blood samples versus peripheral blood samples: a clinical validation study

Determination of cyclosporine levels in central venous blood samples versus peripheral blood samples: a clinical validation study - VCSA study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50893

Enrollment

Registered

2021-03-30

Start date

2021-04-09

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogene stamceltransplantatie Cyclosporine blood level cyclosporine medication level

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Eighteen years or older; * Treated with an allogeneic stem cell transplant; * CVC with at least 2 lumens; * Treatment indication for intravenous cyclosporine; * Understanding the Dutch language in words and writing;

Exclusion criteria

Exclusion criteria: - Earlier treatment with intravenous cyclosporine through the CVC; - CVC with less than two lumens

Design outcomes

Primary

Measure	Time frame
Difference between the CsA levels in blood collected from the CVC versus blood collected by means of a venipuncture.	—

Secondary

Measure	Time frame
n.a.	—

Countries

Netherlands

Outcome results